Edward P. Sloan, MD, MPH, FACEP EMRA /FERNE Case Conference: The ED Management of TIA, AIS and ICH Patients.

Slides:



Advertisements
Similar presentations
Edward P. Sloan, MD, MPH, FACEP Research Lecture : Basic Statistics.
Advertisements

Management of Stroke and Transient Ischaemic Attack Sam Thomson.
Latha G. Stead, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Update on Anti-platelets Gabriel A. Vidal, MD Vascular Neurology Ochsner Medical Center October 14 th, 2009.
Edward P. Sloan, MD, MPH FERNE/EMRA Session: Treating Ischemic Stroke Patients Using a 3 to 4.5 Hour tPA Window.
Edward P. Sloan, MD, MPH, FACEP Successful Grantsmanship Private Grant Writing.
Edward P. Sloan, MD, MPH, FACEP ED Ischemic Stroke Patient Management: Optimal Diagnostic and Treatment Strategies.
Copyright © 2008 Delmar Learning. All rights reserved. Unit 43 Nervous System.
ED TIA Patient Case Presentation Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral.
Edward P. Sloan, MD, MPH ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED (mimickers, stroke scales, and CT interpretation)?
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Edward P. Sloan, MD, MPH ACEP Clinical Policy Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department.
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Richard Shih, MD, FACEP The Diagnosis and Management of ED Headache Patients: When Must Cranial CT and LP Both Be Performed in Order to Exclude the Diagnosis.
Andrew Zinkel, MD EMRA /FERNE Case Conference: The ED Management of Acute Ischemic Stroke Patients.
Stroke Issues & prevention. Agenda  Impact of Stroke –Definitions –Epidemiology –Risk factors  Management of Stroke –Acute management –Primary & Secondary.
Edward P. Sloan, MD, MPH, FACEP The Management of ED Seizure and Status Epilepticus Patients: The Role of 1st & 2nd Generation Anti-epileptic Drugs in.
The Management of ED TIA Patients:
Edward P. Sloan, MD, MPH, FACEP Conducting Successful EM Resident Research: Generating Research Ideas and Hypotheses.
TPA in Acute Ischemic Stroke: The NINDS Reanalysis & Meta-analysis Data Sidney Starkman, MD, FACEP.
Andrew Asimos, MD, FACEP Stroke Patient and Stroke Therapies Assessment: ED NIHSS & Stroke Scales Use for ED Stroke Therapies.
T-PA in Treatment of Acute Stroke: What We Know From NINDS 2004 vs 2000 Sidney Starkman, MD Departments of Emergency Medicine and Neurology, UCLA UCLA.
Brian J. O’Neil MD, FACEP The Management of TIA Patients: The Science and the Practice.
Preventing Strokes One at a Time Evaluating the Event 2009.
Edward P. Sloan, MD, MPH, FACEP Emergency Department Patient Hypertensive Emergencies: Published Guidelines, Articles, & Their Findings.
OVBIAGELE B, DIENER H-C, YUSUF S, ET AL., PROFESS INVESTIGATORS. LEVEL OF SYSTOLIC BLOOD PRESSURE WITHIN THE NORMAL RANGE AND RISK OF RECURRENT STROKE.
FERNE/EMRA The Management of ED TIA Patients: What is the optimal outpatient work-up, treatment and disposition?
Michael Ross, MD, FACEP The Management of ED TIA Patients: Can We Send Them Home, and What Work-up Must Be Done First?
FERNE/MEMC Session: Treating Ischemic Stroke in the 3 – 4
Edward P. Sloan, MD, MPH FERNE/EMA Session: Treating Ischemic Stroke Patients Using a 3 to 4.5 Hour tPA Window.
Acute Ischemic Stroke Management: 2004 Emergency Medicine Perspectives.
Jonathan A. Edlow, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral.
Transient Ischemic Attack (TIA): The Calm Before the Storm
Andrew Asimos, MD, FACEP ED Transient Ischemic Attack Patient Management: Can At-risk Ischemic Stroke Patients Be Identified?
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
High Risk TIA: Identification and Management Carolyn Walker RN. BN January 2011.
Edward P. Sloan, MD, MPH EMRA/FERNE Neurological Emergencies Case Conference Special Panel Discussion: Tell me One Thing About Emergency Medicine.
Edward P. Sloan, MD, MPH, FACEP Current Updates on Ischemic Stroke, ICH, and SAH.
TIA Hotline (ASPIRE Project) and TIA Management Thomas Jeerakathil BSc, MD, MSc, FRCP(C) February 23rd, 2009 Telehealth Presentation.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Benefits of Urgent Evaluation and Treatment for TIA and Minor Stroke Summary and Comment by Kristi L. Koenig, MD, FACEP Published in Journal Watch Emergency.
FERNE/EMRA How do we treat ICH patients with an elevated INR Andy Jagoda, MD, FACEP Professor and Vice Chair Department of Emergency Medicine Mount Sinai.
Metabolic Syndrome and Recurrence within the 21-Gene Recurrence Score Assay Risk Categories in Lymph Node Negative Breast Cancer Lakhani A et al. Proc.
10 May 2005 CASES - Original article available at CASES (Canadian Alteplase for Stroke Effectiveness Study) The CASES Investigators.
Edward P. Sloan, MD, MPH, FACEP EMRA /FERNE Case Conference: The ED Management of TIA, AIS and ICH Patients.
Andrew W. Asimos, MD How Can We Use Advanced Neuroimaging in the ED to Optimize Treatment Options for Acute Stroke Patients?
Characteristics of patients included in the OCSP cohort used to derive the risk score and the three other cohorts used to validate the score P.M. Rothwell,et.
Long-term mortality after acute stroke  Stroke is a leading cause of mortality: 6 million fatal events annually worldwide.  Mainly affects elderly, but.
Edward P. Sloan, MD, MPH, FACEP Ischemic Stroke Patient Care: tPA Use in 2007.
Edward C. Jauch, MD, MS FACEP 1 Research Horizons in the Acute Management of ICH.
DR AMER JAFAR ‘STROKE’ October Ethnicity and recurrence of stroke Population-based study Compared poststroke recurrence and survival in Mexican.
Andreas A. Rostved, MD Research assistant Department of Surgical Gastroenterology and Transplantation Rigshospitalet – Copenhagen University Hospital Denmark.
FERNE/EMRA ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED (mimickers, stroke scales, and CT interpretation)?
Edward P. Sloan, MD, MPH, FACEP EMRA /FERNE Case Conference: The ED Management of Acute Ischemic Stroke Patients.
Validation and Refinement of a Prediction Rule to Identify Children at Low Risk for Acute Appendicitis Kharbanda AB, Dudley NC, Bajaj L, et al; Pediatric.
Richard Shih, MD, FACEP Stroke Patient Management Using IV tPA: When and How Should It Be Utilized in ED Patients?
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Risk of stroke following transient ischaemic.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Risk of stroke following transient ischaemic.
Risk of stroke at 3 months6 Expected Strokes at 3 months
Risk Stratification of Chest Pain: Best Practices
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
Setareh Omran, MD Vascular Neurology Fellow
TIA for the Internist The American Journal of Medicine
TIA/Stroke (1) C.L.I.P.S. Why do we care?
Update from education committee
Presentation transcript:

Edward P. Sloan, MD, MPH, FACEP EMRA /FERNE Case Conference: The ED Management of TIA, AIS and ICH Patients

Edward P. Sloan, MD, MPH, FACEP ACEP Scientific Assembly New Orleans, LA October 15-18, 2006

FERNE/EMRA Can We Risk Stratify TIA Patients in the ED?

FERNE/EMRA Andrew Asimos, MD, FACEP Adjunct Associate Professor Department of Emergency Medicine University of North Carolina School of Medicine at Chapel Hill Chapel Hill, NC

FERNE/EMRA Attending Physician Emergency Medicine Director of Emergency Stroke Care Carolinas Medical Center Department of Emergency Medicine Charlotte, NC

FERNE/EMRA Stroke Risk after TIA Johnston SC et al. JAMA 2000;284: Kleindorfer K et al. Stroke 2005;26: Lovett JK et al. Stroke (8): Coull AJ et al. BMJ (7435):326. Gladstone DJ et al. CMAJ (7): Hill MD et al. Neurology (11): Kaiser 2000 (n=1,707) Oxford CP 2003 (n=209) Oxford VS 2004 (n=87) Alberta 2004 (n=2,285) Ontario 2004 (n=265) GCNK 2005 (n=927) 2 Days5% 3% 4% 7 Days9%8%4%7% 1 Month12% 5%11% 3 Months11%17%10%6%15% 6 Months17% 1 Year15%

FERNE/EMRA JAMA, December 13, 2000

FERNE/EMRA

Independent Risk Factors for Stroke within 90 Days Odds Ratio (95% CI) P Value Age > ( ) 0.01 Diabetes Mellitus 2.0 ( ) <0.001 > 10 min Duration 2.3 ( ) Weakness 1.9 ( ) <0.001 Speech Impairment 1.5 ( ) 0.01 Johnston SC et al. JAMA 2000;284:

FERNE/EMRA 90-Day Stroke Risk by Number of Risk Factors # (%) # Risk Factors Patients Stroke within 90 days 0 22 (1) 0 (0) (10) 5 (3) (30) 36 (7) (34) 63 (11) (20) 51 (15) 5 76 (4) 26 (34) Johnston SC et al. JAMA 2000;284:

FERNE/EMRA

ABCD Score Risk Factor Score Age ≥60 1 SBP >140 mm Hg and /or DBP ≥90 mm Hg 1 Unilateral weakness 2 Speech disturbance without weakness 1 Symptom duration ≥60 minutes 2 Symptom duration minutes 1 Symptom duration <10 minutes 0 Rothwell et al. Lancet 2005;366:29-36.

FERNE/EMRA 7-Day Stroke Risk Stratified by ABCD Score: OXVASC Validation Cohort Rothwell et al. Lancet 2005;366:29-36.

FERNE/EMRA Is the ABCD Score Useful for Risk Stratification of Patients With Acute TIA? Prospective study of 117 TIA patients over 3 years Prospective study of 117 TIA patients over 3 years Diagnosed by a neurologist, using the classic <24-hour definition Diagnosed by a neurologist, using the classic <24-hour definition Hospitalized within 48 hours of symptom onset Hospitalized within 48 hours of symptom onset Cucchiara BL et al. Stroke 2006; 37(7):

FERNE/EMRA Is the ABCD Score Useful for Risk Stratification of Patients With Acute TIA? Primary Outcome Measure was Primary Outcome Measure was Dichotomization of subjects into high- risk and low-risk categories Dichotomization of subjects into high- risk and low-risk categories High-risk group High-risk group –Stroke or death within 90 days –≥50% stenosis in a vessel referable to symptoms –Cardioembolic source warranting anticoagulation Cucchiara BL et al. Stroke 2006; 37(7):

FERNE/EMRA Results 26 patients (22%) classified as high risk 26 patients (22%) classified as high risk Clinical events occurred in 4 patients Clinical events occurred in 4 patients 2 strokes, 2 deaths 2 strokes, 2 deaths A ≥50% stenosis in a vessel referable to the patient’s symptoms was found in 15 patients (14%) A ≥50% stenosis in a vessel referable to the patient’s symptoms was found in 15 patients (14%) A cardioembolic source warranting anticoagulation was found in 10 patients (9%) A cardioembolic source warranting anticoagulation was found in 10 patients (9%) Cucchiara BL et al. Stroke 2006; 37(7):

FERNE/EMRA Results Increasing ABCD scores marginally associated with increasing risk Increasing ABCD scores marginally associated with increasing risk ABCD scores in the 2 patients with stroke were 3 and 6 ABCD scores in the 2 patients with stroke were 3 and 6 Strokes occurred 26 hours and 39 hours after TIA onset Strokes occurred 26 hours and 39 hours after TIA onset Both patients who died had an ABCD score of 5 Both patients who died had an ABCD score of 5 Patients without weakness or speech disturbance still had significant probability of being high risk (15%) or DWI+ (8%) Patients without weakness or speech disturbance still had significant probability of being high risk (15%) or DWI+ (8%) Cucchiara BL et al. Stroke 2006; 37(7):

FERNE/EMRA Is the ABCD Score Useful for Risk Stratification of Patients With Acute TIA? Discriminatory ability of ABCD score not optimal Discriminatory ability of ABCD score not optimal Patients with a score of 0 to 3 still had a clinically significant probability of having stroke within 90 days, or a high-risk cause of cerebral ischemia warranting specific intervention Patients with a score of 0 to 3 still had a clinically significant probability of having stroke within 90 days, or a high-risk cause of cerebral ischemia warranting specific intervention Roughly in the 10% to 20% range Roughly in the 10% to 20% range Similar percentage had evidence of ischemia on early MRI Similar percentage had evidence of ischemia on early MRI Cucchiara BL et al. Stroke 2006; 37(7):

FERNE/EMRA Conclusions Prediction rules require prospective validation Isolated visual or sensory symptoms suggest low short term risk for stroke Role of DWI MRI in short term stroke risk stratification needs further investigation

FERNE/EMRA Questions? ferne_emra_2006_asimos_tiarisk_101506_finalcd 8/13/2015 1:48 PM